Qiagen N.V. QGEN
49.88 USD -0.01 (-0.02%)
As ofNov 16, 2026, 12:18 PM EST
49.79 Day range 49.95
32.53 52-week range 57.82
- YTD
- +10.92%
- 1 year
- +12.55%
News
zacks.com Interpreting Qiagen (QGEN) International Revenue Trends Review Qiagen's (QGEN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.benzinga.com Qiagen Q3 Adj. EPS $0.65, Inline, Sales $548.000M Miss $573.331M Estimate Qiagen (NYSE:QGEN) reported quarterly earnings of $0.65 per share which met the analyst consensus estimate. This is a 12.07 percent increase over earnings of $0.58 per share from the same period last…
benzinga.com Barclays Downgrades Qiagen to Equal-Weight, Lowers Price Target to $53 Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and lowers the price target from $55 to $53.
benzinga.com Citigroup Maintains Neutral on Qiagen, Raises Price Target to $52 Citigroup analyst Albert Hu maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $45 to $52.
benzinga.com Long-Awaited Qiagen Buyout Closes At 15x EBITDA Multiple as Slow Growth Curbs Pricing Qiagen agrees to a $12 billion all-cash buyout by EQT. Analysts view the valuation discount as warranted given slower growth.
benzinga.com This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46.benzinga.com JP Morgan Downgrades Qiagen to Neutral, Lowers Price Target to $52 JP Morgan analyst Casey Woodring downgrades Qiagen (NYSE:QGEN) from Overweight to Neutral and lowers the price target from $55 to $52.
benzinga.com Baird Maintains Outperform on Qiagen, Raises Price Target to $52 Baird analyst Catherine Schulte maintains Qiagen (NYSE:QGEN) with a Outperform and raises the price target from $50 to $52.
benzinga.com QIAGEN Reports Preliminary Q3 Net Sales Of $548M; Preliminary Q3 Adj EPS $0.65; Co. Suspends FY 2026 Outlook While Transaction With EQT Private Equity Is Pending QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates…
benzinga.com Qiagen And EQT Private Equity Agree On An All-Cash Public Takeover Offer For All Outstanding Qiagen Shares At An Offer Price Of €46.50 Per Share, A Premium Of 40.3% To The Unaffected Share Price; Closing Expected In Mid-2027 QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an offer price of €46.50 per share, a premium of 40.3% to the unaffected share…
benzinga.com 'EQT Is in Advanced Talks to Buy Testing Firm Qiagen' - Bloomberg -Bloomberg.
